Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Professor Chris Lavy, who has been appointed to the World Health Organization’s (WHO) technical advisory group for integrated clinical care for a period of two years.

Photo of Chris Lavy

The Technical Advisory Group on Integrated Clinical Care (the TAG-IC2) is a 22-strong member group of experts which advises WHO in the areas of clinical primary, emergency, operative, and critical care. Prof. Lavy is one of five members of a team that will advise WHO in the area of operative (surgical) care.  

“Our team will be reviewing guidelines, publications and other sorts of who materials in the surgical field and looking at setting out new ones if necessary,” said Chris. “In particular I’ll be looking at orthopaedics and trauma care.” 

One of Chris’s orthopaedic research interests is clubfoot and he’s set up the international Global Clubfoot Initiative to share expertise in clubfoot management. “We’ve discovered a lot about clubfoot through our studies, teaching and by delivering treatment to patients and children born with the condition. But as yet there is no global policy on its treatment. One of the reasons I’m part of the technical advisory group, is to help bring together some of the great ideas that have been tested across national programmes and diseases to be branded as global guidelines and protocols by the WHO.” 

The core functions of the TAG-IC2 are: 

  1. To provide independent evaluation of the scientific technical and strategic aspects of primary, emergency, operative, and critical care; 

  1. To advise WHO on the scope and characteristics of clinical care guidance documents; 

  1. To provide support and advice to WHO on evidence retrieval and synthesis; 

  1. To provide advice to WHO on validation of clinical recommendations through expert review; 

  1. To provide advice to WHO on validation of curricula and learning modules; 

  1. To identify areas where ad-hoc experts are needed to provide additional review. 

Similar stories

Study challenges fears over blood-clot risk from painkillers and hormonal contraception

Women using hormonal contraception who are prescribed common anti-inflammatory painkillers may not face a drug-related increase in blood-clot risk despite previous research, according to a new DARWIN EU® study.

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8th October 2026.

Adam Croft appointed Norman Collisson Professor of Musculoskeletal Science

This appointment brings a further focus to linking rheumatology discovery science and clinical trials in NDORMS, strengthening translational rheumatology research across the department to deliver transformative treatments for patients with inflammatory arthritis.

NIHR fellowship to support national trial evaluating rehabilitation after kneecap dislocation

Dr Colin Forde has been awarded a National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) Postdoctoral Award to lead a national study evaluating rehabilitation for people with a kneecap (patellar) dislocation.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Professor Afsie Sabokbar retires after more than 30 years at NDORMS

Botnar Institute Director of Graduate Studies, Professor Afsie Sabokbar, is retiring after more than 30 years at NDORMS.